BIOMARIN PHARMACEUTICAL INC Active Patents
62 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2024-01-29: Application 18425954; Invention Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia; Applicant BIOMARIN PHARMACEUTICAL INC.; Status Patented Case.
- 2023-01-20: Application 18157573; Invention Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia; Applicant BIOMARIN PHARMACEUTICAL INC.; Status Patented Case.
- 2022-07-11: Application 17811748; Invention C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia in Children; Applicant BIOMARIN PHARMACEUTICAL INC.; Status Patented Case.
- 2022-05-18: Application 17747697; Invention COMPOSITIONS OF PROKARYOTIC PHENYLALANINE AMMONIA-LYASE AND METHODS OF TREATING ADOLESCENT SUBJECTS; Applicant BIOMARIN PHARMACEUTICAL INC.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-29 | 18425954 | Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2026-01-06 | 12514906 | US20240156914A1 | Sherry Bullens Stuart Bunting Tianwei Chou Augustus O. Okhamafe Christopher P. Price Daniel J. Wendt Clarence Yap | United States United States United States United States Germany United States Canada | XIE, XIAOZHEN |
| 2023-01-20 | 18157573 | Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2024-09-03 | 12076372 | US20230293637A1 | Sherry Bullens Stuart Bunting Tianwei Chou Augustus O. Okhamafe Christopher P. Price Daniel J. Wendt Clarence Yap | United States United States United States United States Germany United States United States | HELLMAN, KRISTINA M |
| 2022-07-11 | 17811748 | C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia in Children | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2025-02-25 | 12233106 | US20230140311A1 | Jonathan Day Elena Fisheleva | United Kingdom United States | HA, JULIE |
| 2022-05-18 | 17747697 | COMPOSITIONS OF PROKARYOTIC PHENYLALANINE AMMONIA-LYASE AND METHODS OF TREATING ADOLESCENT SUBJECTS | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2024-03-05 | 11918633 | US20220370576A1 | Debra LOUNSBURY | United States | SAIDHA, TEKCHAND |
| 2021-12-03 | 17541992 | USE OF C-TYPE NATRIURETIC PEPTIDE VARIANTS TO TREAT OSTEOARTHRITIS | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2025-02-04 | 12214015 | US20220160836A1 | Charles A. O'Neill Todd M. Oppeneer Jason K. Pinkstaff | United States United States United States | XIE, XIAOZHEN |
| 2021-03-01 | 17188994 | MANUFACTURE OF ACTIVE HIGHLY PHOSPHORYLATED HUMAN LYSOSOMAL SULFATASE ENZYMES AND USES THEREOF | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2025-01-07 | 12188058 | US20210189357A1 | Erno Pungor Charles Hague Zhi Chen Melita Dvorak-Ewell Michel Claude Vellard Vish Koppaka | United States United States United States United States United States United States | SAIDHA, TEKCHAND |
| 2020-07-28 | 16941454 | TPP-1 Formulations and Methods for Treating CLN2 Disease | BioMarin Pharmaceutical Inc. | Patented Case | 2022-01-25 | 11229687 | US20200353059A1 | Thomas Lester Saeed Moshashaee Augustus O. Okhamafe Charles A. O'Neill | United States United States United States United States | FONTAINHAS, AURORA M |
| 2020-04-01 | 16837910 | Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia | BioMarin Pharmaceutical Inc. | Patented Case | 2023-02-28 | 11590204 | US20200246434A1 | Sherry Bullens Stuart Bunting Tianwei Chou Augustus O Okhamafe Christopher P. Price Daniel J. Wendt Clarence Yap | United States United States United States United States Germany United States United States | HELLMAN, KRISTINA M |
| 2020-04-01 | 16837905 | Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia | BioMarin Pharmaceutical Inc. | Patented Case | 2024-02-27 | 11911446 | US20200246433A1 | Sherry Bullens Stuart Bunting Tianwei Chou Augustus O. Okhamafe Christopher P. Price Daniel J. Wendt Clarence Yap | United States United States United States United States Germany United States United States | XIE, XIAOZHEN |
| 2020-02-06 | 16783589 | Manufacture of Active Highly Phosphorylated Human Lysosomal Sulfatase Enzymes and Uses Thereof | BioMarin Pharmaceutical Inc. | Patented Case | 2021-03-02 | 10934534 | US20200181590A1 | Erno Pungor Charles Hague Zhi Chen Melita Dvorak-Ewell Michel Claude Vellard Vish Koppaka | United States United States United States United States United States United States | SAIDHA, TEKCHAND |
| 2019-11-06 | 16675841 | ADENO-ASSOCIATED VIRUS FACTOR VIII VECTORS, ASSOCIATED VIRAL PARTICLES AND THERAPEUTIC FORMULATIONS COMPRISING THE SAME | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2023-07-04 | 11690898 | US20200061161A1 | Stuart Bunting Peter Cameron Colosi Erno Pungor | United States United States United States | MARVICH, MARIA |
| 2019-05-14 | 16411848 | Novel Liver Targeting Adeno-Associated Viral Vectors | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2023-11-21 | 11821008 | US20200024579A1 | Peter Cameron Colosi Silvia Ramirez | United States United States | ARON, KIMBERLY A |
| 2019-05-08 | 16407015 | METHODS OF TREATING PHENYLKETONURIA | BioMarin Pharmaceutical Inc. | Patented Case | 2023-08-29 | 11739345 | US20190376081A1 | Geoffrey Berguig Rajeev Mahimkar Hassibullah Akeefe Peter Colosi | United States United States United States United States | MARVICH, MARIA |
| 2019-04-08 | 16378163 | Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof | BioMarin Pharmaceutical Inc. | Patented Case | 2022-02-22 | 11254725 | US20190225666A1 | Mika Aoyagi-Scharber Teresa Margaret Christianson Melita Dvorak-Ewell Daniel J. Wendt Shinong Long Jonathan LeBowitz Daniel Solomon Gold | United States United States United States United States United States United States United States | RAMIREZ, DELIA M |
| 2019-03-28 | 16368091 | TPP-1 Formulations and Methods for Treating CLN2 Disease | BioMarin Pharmaceutical Inc. | Patented Case | 2020-09-01 | 10758598 | US20190216905A1 | Thomas Lester Saeed Moshashaee Augustus O. Okhamafe Charles A. O'Neill | United States United States United States United States | FONTAINHAS, AURORA M |
| 2019-02-20 | 16280913 | QUANTIFICATION OF NON-REDUCING END GLYCAN RESIDUAL COMPOUNDS FOR DETERMINING THE PRESENCE, IDENTITY, OR SEVERITY OF A DISEASE OR CONDITION | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2020-10-06 | 10793894 | US20190249224A1 | Brett E. CRAWFORD Jillian R. BROWN Charles A. GLASS Jim R. BEITEL Robin M. JACKMAN | United States United States United States United States United States | GITOMER, RALPH J |
| 2019-02-12 | 16274117 | N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS | BioMarin Pharmaceutical Inc. | Patented Case | 2022-06-14 | 11358932 | US20190276398A1 | Bing Wang | United States | SOROUSH, LAYLA |
| 2019-01-31 | 16264505 | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES | BioMarin Pharmaceutical Inc. | Patented Case | 2021-02-23 | 10927092 | US20190263775A1 | Bing Wang Daniel Chu Alexander James Bridges | United States United States United States | JEAN-LOUIS, SAMIRA JM |
| 2019-01-23 | 16319877 | NOVEL ADENO-ASSOCIATED VIRUS CAPSID PROTEINS | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2023-02-21 | 11584780 | US20220402974A1 | Peter Cameron Colosi Michael LOCHRIE Robert NG | United States United States United States | GRABER, JAMES J |
| 2019-01-11 | 16246300 | COMPOSITIONS OF PROKARYOTIC PHENYLALANINE AMMONIA-LYASE VARIANTS AND METHODS OF USING COMPOSITIONS THEREOF | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2022-11-22 | 11505790 | US20190345475A1 | Augustus O. Okhamafe Sean M. Bell G. Nick Zecherle Kris Antonsen Yanhong Zhang Kieu Ly Tran Paul A. Fitzpatrick Emil D. Kakkis Michel Claude Vellard Daniel J. Wendt Mubarack Muthalif | United States United States United States United States United States United States United States United States United States United States United States | PAK, YONG D |
| 2018-08-21 | 16078546 | TARGETED THERAPEUTIC LYSOSOMAL ENZYME FUSION PROTEINS, ASSOCIATED FORMULATIONS AND USES THEREOF | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2022-05-31 | 11345904 | US20200297821A1 | SAEED MOSHASHAEE JASON K. PINKSTAFF ADAM SHAYWITZ NATALIE CIACCIO | United States United States United States United States | PAK, YONG D |
| 2018-07-27 | 16047179 | HISTONE DEACETYLASE INHIBITORS | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2019-06-04 | 10308608 | US20180370915A1 | Shripad Bhagwat Gregory Luedtke Alexander Bridges | United States United States United States | KIFLE, BRUCK |
| 2018-05-24 | 15779049 | USE OF C-TYPE NATRIURETIC PEPTIDE VARIANTS TO TREAT OSTEOARTHRITIS | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2021-12-21 | 11202819 | US20190247467A1 | CHARLES A. O'NEILL TODD M. OPPENEER JASON K. PINKSTAFF | United States United States United States | XIE, XIAOZHEN |
| 2018-05-04 | 15773822 | Cell-Based Assays for Detection of Antibodies or Other Factors That Neutralize Uptake of Lysosomal Enzymes | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2022-03-01 | 11262348 | US20180321221A1 | Andrew Melton Stephen Zoog Lynne Jesaitis | United States United States United States | GIERE, REBECCA M |
| 2018-02-08 | 15892409 | METHODS OF DIAGNOSING MUCOPOLYSACCHARIDOSIS (MPS) I AND METHODS OF MONITORING TREATMENT OF MPS BY QUANTIFYING A NON-REDUCING END GLYCAN RESIDUAL COMPOUND AND COMPARING TO A SECOND BIOMARKER | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2020-06-09 | 10677786 | US20180259507A1 | Brett E. CRAWFORD Jillian R. BROWN Charles A. GLASS Jim R. BEITEL Robin M. JACKMAN | United States United States United States United States United States | GITOMER, RALPH J |
| 2018-01-25 | 15880002 | USE OF C-TYPE NATRIURETIC PEPTIDE VARIANTS TO TREAT SKELETAL DYSPLASIA | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2020-05-12 | 10646550 | US20180207239A1 | SHERRY BULLENS STUART BUNTING TIANWEI CHOU AUGUSTUS O. OKHAMAFE CHRISTOPHER P. PRICE DANIEL J. WENDT CLARENCE YAP | United States United States United States United States Germany United States United States | SHAFER, SHULAMITH H |
| 2018-01-12 | 15869549 | Manufacture of Active Highly Phosphorylated Human Lysosomal Sulfatase Enzymes and Uses Thereof | BioMarin Pharmaceutical Inc. | Patented Case | 2020-02-18 | 10563183 | US20180208913A1 | Erno Pungor Charles Hague Zhi Chen | United States United States United States | SAIDHA, TEKCHAND |
| 2017-12-28 | 15740437 | HISTONE DEACETYLASE INHIBITORS | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2020-12-01 | 10851058 | US20190382342A1 | Shripad Bhagwat Gregory Luedtke Alexander Bridges | United States United States United States | KIFLE, BRUCK |
| 2017-09-15 | 15705677 | DETECTION OF OLIGOSACCHARIDES | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2020-06-16 | 10683530 | US20180080059A1 | Brett E. CRAWFORD Jillian R. BROWN Charles A. GLASS | United States United States United States | OLSON, ANDREA STEFFEL |
| 2017-09-08 | 15556786 | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2019-03-12 | 10227312 | US20180044302A1 | Bing Wang | United States | STOCKTON, LAURA LYNNE |
| 2017-08-28 | 15688438 | Nucleic Acids Encoding Targeted Therapeutic Lysosomal Enzyme Fusion Proteins | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2019-05-28 | 10301369 | US20170355744A1 | MIKA AOYAGI-SCHARBER TERESA MARGARET CHRISTIANSON MELITA DVORAK-EWELL DANIEL J. WENDT SHINONG LONG JONATHAN LeBOWITZ DANIEL SOLOMON GOLD | United States United States United States United States United States United States United States | RAMIREZ, DELIA M |
| 2017-07-26 | 15660936 | TARGETED THERAPEUTIC PROTEINS | BioMarin Pharmaceutical Inc. | Patented Case | 2019-05-28 | 10300113 | US20180055911A1 | Jonathan LeBowitz Stephen M. Beverley | United States United States | GAMETT, DANIEL C |
| 2017-07-24 | 15657764 | LYSOSOMAL TARGETING PEPTIDES AND USES THEREOF | BioMarin Pharmaceutical Inc. | Patented Case | 2022-06-07 | 11351231 | US20180125949A1 | Jonathan LeBowitz John Maga | United States United States | ALLEN, MARIANNE P |
| 2017-07-11 | 15646822 | Variants of C-Type Natriuretic Peptide | BioMarin Pharmaceutical Inc. | Patented Case | 2020-10-20 | RE48267 | Daniel J. Wendt Shinong Long Sianna Castillo Christopher P. Price Mika Aoyagi-Scharber Michel Claude Vellard Augustus O. Okhamafe | United States United States United States Germany United States United States United States | CAMPELL, BRUCE R | |
| 2017-05-12 | 15594162 | QUANTIFICATION OF NON-REDUCING END GLYCAN RESIDUAL COMPOUNDS FOR DETERMINING THE PRESENCE, IDENTITY, OR SEVERITY OF A DISEASE OR CONDITION | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2019-04-16 | 10260084 | US20170321246A1 | Brett E. CRAWFORD Jillian R. BROWN Charles A. GLASS Jim R. BEITEL Robin M. JACKMAN | United States United States United States United States United States | GITOMER, RALPH J |
| 2016-09-23 | 15274046 | Adeno-Associated Virus Factor VIII Vectors, Associated Viral Particles and Therapeutic Formulations Comprising the Same | BioMarin Pharmaceutical Inc. | Patented Case | 2019-12-24 | 10512675 | US20170087219A1 | Stuart Bunting Peter Cameron Colosi Erno Pungor | United States United States United States | MARVICH, MARIA |
| 2016-08-01 | 15225355 | USE OF C-TYPE NATRIURETIC PEPTIDE VARIANTS TO TREAT SKELETAL DYSPLASIA | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2018-03-06 | 9907834 | US20170028023A1 | Sherry Bullens Stuart Bunting Tianwei Chou Augustus O. Okhamafe Christopher P. Price Daniel J. Wendt Clarence Yap | United States United States United States United States Germany United States United States | SHAFER, SHULAMITH H |
| 2016-05-05 | 15147485 | TPP-1 FORMULATIONS AND METHODS FOR TREATING CLN2 DISEASE | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2019-05-07 | 10279015 | US20160324942A1 | Thomas W. Lester Saeed Moshashaee Augustus O. Okhamafe Charles A. O' Neill | United States United States United States United States | FONTAINHAS, AURORA M |
| 2016-04-27 | 15032613 | N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2019-03-26 | 10239832 | US20160280643A1 | Bing Wang | United States | KAROL, JODY LYNN |
| 2016-04-15 | 15130694 | COMPOSITIONS OF PROKARYOTIC PHENYLALANINE AMMONIA-LYASE VARIANTS AND METHODS OF USING COMPOSITIONS THEREOF | BioMarin Pharmaceutical Inc. | Patented Case | 2019-03-05 | 10221408 | US20160362675A1 | Augustus O. Okhamafe Sean M. Bell G. Nick Zecherle Kris Antonsen Yanhong Zhang Kieu Ly Tran Paul A. Fitzpatrick Emil D. Kakkis Michel Claude Vellard Daniel J. Wendt Mubarack Muthalif | United States United States United States United States United States United States United States United States United States United States United States | PAK, YONG D |
| 2016-03-18 | 15023337 | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2019-03-12 | 10227323 | US20160229830A1 | Bing Wang Daniel Chu Alexander James Bridges | United States United States United States | JEAN-LOUIS, SAMIRA JM |
| 2015-12-01 | 14956179 | QUANTIFICATION OF NON-REDUCING END GLYCAN RESIDUAL COMPOUNDS FOR DETERMINGING THE PRESENCE, IDENTITY, OR SEVERITY OF A DISEASE OR CONDITION | BioMarin Pharmaceutical Inc. | Patented Case | 2017-06-13 | 9677116 | US20160153024A1 | Brett E. Crawford Jillian R. Brown Charles A. Glass Jim R. Beitel Robin M. Jackman | United States United States United States United States United States | GITOMER, RALPH J |
| 2015-10-27 | 14924405 | MANUFACTURE OF ACTIVE HIGHLY PHOSPHORYLATED HUMAN LYSOSOMAL SULFATASE ENZYMES AND USES THEREOF | BioMarin Pharmaceutical Inc. | Patented Case | 2018-01-23 | 9873867 | US20160201039A1 | Erno Pungor Charles Hague Zhi Chen | United States United States United States | SAIDHA, TEKCHAND |
| 2015-10-14 | 14883211 | Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof | BioMarin Pharmaceutical Inc. | Patented Case | 2017-09-26 | 9771408 | US20160039900A1 | Mika Aoyagi-Scharber Teresa Margaret Christianson Melita Dvorak-Ewell Daniel J. Wendt Shinong Long Jonathan LeBowitz Daniel Solomon Gold | United States United States United States United States United States United States United States | RAMIREZ, DELIA M |
| 2015-10-14 | 14883203 | Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof | BioMarin Pharmaceutical Inc. | Patented Case | 2017-12-05 | 9834588 | US20160031965A1 | Mika Aoyagi-Scharber Teresa Margaret Christianson Melita Dvorak-Ewell Daniel J. Wendt Shinong Long Jonathan LeBowitz Daniel Solomon Gold | United States United States United States United States United States United States United States | RAMIREZ, DELIA M |
| 2015-10-14 | 14883193 | Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof | BioMarin Pharmaceutical Inc. | Patented Case | 2017-12-05 | 9834587 | US20160031964A1 | Mika Aoyagi-Scharber Teresa Margaret Christianson Melita Dvorak-Ewell Daniel J. Wendt Shinong Long Jonathan LeBowitz Daniel Solomon Gold | United States United States United States United States United States United States United States | RAMIREZ, DELIA M |
| 2015-10-14 | 14883169 | Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof | BioMarin Pharmaceutical Inc. | Patented Case | 2017-12-19 | 9845346 | US20160031963A1 | Mika Aoyagi-Scharber Teresa Margaret Christianson Melita Dvorak-Ewell Daniel J. Wendt Shinong Long Jonathan LeBowitz Daniel Solomon Gold | United States United States United States United States United States United States United States | RAMIREZ, DELIA M |
| 2015-06-16 | 14741339 | ASSAYS FOR DETECTION OF PHENYLALANINE AMMONIA-LYASE AND ANTIBODIES TO PHENYLALANINE AMMONIA-LYASE | BioMarin Pharmaceutical Inc. | Patented Case | 2017-01-31 | 9557340 | US20160139144A1 | Erik Damien Foehr Bin Zhao Carlos Fabricio Santamaria | United States United States United States | YAMASAKI, ROBERT J |
| 2015-05-07 | 14706794 | DETECTION OF OLIGOSACCHARIDES | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2017-10-24 | 9796999 | US20150307915A1 | Brett E. CRAWFORD Jillian R. BROWN Charles A. GLASS | United States United States United States | OLSON, ANDREA STEFFEL |
| 2015-01-23 | 14604262 | Variants of C-Type Natriuretic Peptide | BioMarin Pharmaceutical Inc. | Patented Case | 2018-02-13 | RE46707 | Daniel J. Wendt Shinong Long Sianna Castillo Christopher P. Price Mika Aoyagi-Scharber Michel Claude Vellard Augustus O. Okhamafe | United States United States United States Germany United States United States United States | RAILEY, JOHNNY F | |
| 2014-12-17 | 14573907 | MANUFACTURE OF ACTIVE HIGHLY PHOSPHORYLATED HUMAN N-ACETYLGALACTOSAMINE-6-SULFATASE AND USES THEREOF | BioMarin Pharmaceutical Inc. | Patented Case | 2017-02-14 | 9567572 | US20160186149A1 | Vish Koppaka Michel Claude Vellard Augustus O. Okhamafe Kidisti Araya | United States United States United States United States | LEE, JAE W |
| 2014-11-07 | 14535505 | LYSOSOMAL TARGETING PEPTIDES AND USES THEREOF | BioMarin Pharmaceutical Inc. | Patented Case | 2016-10-18 | 9469683 | US20150064157A1 | Jonathan H. LeBowitz John Maga | United States United States | ALLEN, MARIANNE P |
| 2014-09-10 | 14482648 | ADENO-ASSOCIATED VIRUS FACTOR VIII VECTORS | BioMarin Pharmaceutical Inc. | Patented Case | 2016-11-29 | 9504762 | US20150071883A1 | Peter Cameron Colosi Amit Nathwani Jenny Mcintosh Edwar Tuddenham | United States United Kingdom United Kingdom United Kingdom | WILSON, MICHAEL C |
| 2014-08-18 | 14462285 | METHODS OF DIAGNOSING A DISEASE AND METHODS OF MONITORING TREATMENT OF A DISEASE BY QUANTIFYING A NON-REDUCING END GLYCAN RESIDUAL COMPOUND AND COMPARING TO A SECOND BIOMARKER | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2016-05-17 | 9340822 | US20140356855A1 | Brett E. Crawford Jillian R. Brown Charles A. Glass Jim R. Beitel Robin M. Jackman | United States United States United States United States United States | GITOMER, RALPH J |
| 2014-07-01 | 14321413 | Quantification of Non-Reducing End Glycan Residual Compounds for Determining the Presence, Identity, or Severity of a Disease or Condition | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2015-12-29 | 9222120 | US20140308684A1 | Brett E. Crawford Jilllian R. Brown Charles A. Glass Jim R. Beitel Robin M. Jackman | United States United States United States United States United States | GITOMER, RALPH J |
| 2014-05-19 | 14281538 | MANUFACTURE OF ACTIVE HIGHLY PHOSPHORYLATED HUMAN N-ACETYLGALACTOSAMINE-6-SULFATASE AND USES THEREOF | BioMarin Pharmaceutical Inc. | Patented Case | 2015-01-27 | 8940513 | US20140341878A1 | Vish Koppaka Michel Claude Vellard Augustus Okhamafe Kidisti Araya | United States United States United States United States | LEE, JAE W |
| 2013-11-27 | 14092336 | Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof | BioMarin Pharmaceutical Inc. | Patented Case | 2016-06-28 | 9376480 | US20140161788A1 | Mika Aoyagi-Scharber Teresa Margaret Christianson Melita Dvorak-Ewell Daniel J. Wendt Shinong Long Jonathan LeBowitz Daniel Solomon Gold | United States United States United States United States United States United States United States | RAMIREZ, DELIA M |
| 2013-06-18 | 13920761 | TARGETED THERAPEUTIC PROTEINS | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2014-10-14 | 8859498 | US20140056867A1 | Jonathan LeBowitz Stephen M. Beverley | United States United States | GAMETT, DANIEL C |
| 2013-03-21 | 13848561 | Manufacture of Active Highly Phosphorylated Human Lysosomal Sulfatase Enzymes and Uses Thereof | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2015-12-01 | 9200264 | US20130236921A1 | Erno Pungor Charles Hague Zhi Chen | United States United States United States | SAIDHA, TEKCHAND |
| 2013-03-06 | 13787496 | DIHYDROPYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2015-04-07 | 8999987 | US20130190306A1 | Bing Wang Daniel Chu | United States United States | WARD, PAUL V |
| 2012-11-01 | 13666697 | DRY BLEND FORMULATION OF TETRAHYDROBIOPTERIN | BIOMARIN PHARMACEUTICAL INC. | Patented Case | 2015-12-22 | 9216178 | US20130108694A1 | Tianwei Chou Augustus O. Okhamafe | United States United States | BROWN, COURTNEY A |
| 2012-09-27 | 13629321 | METHODS OF DIAGNOSING A DISEASE AND METHODS OF MONITORING TREATMENT OF A DISEASE BY QUANTIFYING A NON-REDUCING END GLYCAN RESIDUAL COMPOUND AND COMPARING TO A SECOND BIOMARKER | BIOMARIN PHARMACEUTICAL, INC. | Patented Case | 2014-08-19 | 8809009 | US20130217056A1 | Brett E. Crawford Jillian R. Brown Charles A. Glass Jim R. Beitel Robin M. Jackman | United States United States United States United States United States | GITOMER, RALPH J |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |